慢性肾脏病患者代谢综合征常见中医证型与大动脉僵硬度的相关性研究
|
摘要
目的:
探讨伴代谢综合征的慢性肾脏病患者的大动脉僵硬度、体重指数及血脂等指标的变化趋势,为中医证的客观化研究做有益探讨。
方法:
本研究纳入伴代谢综合征的慢性肾脏病患者247例,按临床症状、舌象、脉象辩证,按中医辩证分型,分为六个证型组,即脾肾气虚型组、气阴两虚型组、肝肾阴虚型组、脾肾阳虚型组、痰浊阻遏型组、痰瘀互结型组。其中脾肾气虚型组21例、气阴两虚型组29例,肝肾阴虚型组26例,脾肾阳虚型组43例,痰浊阻遏型组69例,痰瘀互结型组59例。分析证型分布规律,并同时测定其体重指数、腰围、血糖、血脂、血清白蛋白、血清肌酐、血清肌酐清除率、超敏C反应蛋白、颈-股脉搏波速度等指标,分析各证型上述指标的差异以及颈-股脉搏波速与各项相关指标的相关性分析。
结果:
1.伴代谢综合征的慢性肾脏病患者中医辨证以痰浊阻遏型所占比例最大(27%),其后依次为痰瘀互结型(24%)、脾肾阳虚型(17%),气阴两虚型(12%)、肝肾阴虚型(11%)和脾肾气虚型(9%)。
2.各证型组间不同慢性肾脏病分期的比例不一,但在脾肾气虚证组、气阴两虚证组以及肝肾阴虚证组中主要集中以慢性肾脏病1期、2期、3期为主,而在脾肾阳虚证组、痰浊阻遏证组以及痰瘀互结证组中,慢性肾脏病1期、2期、3期比例明显减少,慢性肾脏病4、5期比例明显增多。
3.各证型组的体重指数、腰围、空腹血糖、餐后两小时血糖、甘油三酯、高密度脂蛋白胆固醇、血清肌酐水平、超敏C反应蛋白水平、收缩压、舒张压、脉压以及颈-股脉搏波速均较正常组高,有统计学差异(P＜0.05);各证型组的血清肌酐清除率以及血清白蛋白水平明显低于正常对照组,有统计学差异(P＜0.05)。
4.痰瘀互结证组的体重指数以及腰围均较其它证型组高,有统计学差异(P＜0.05)。各证型组间体重指数比较,痰瘀互结证组与痰浊阻遏证组间比较无统计学差异(P＞0.05),脾肾气虚证组和气阴两虚证组间比较无统计学差异(P＞0.05),其余各组间两两比较均有统计学差异(P＜0.05);各证型组间腰围比较,痰瘀互结证组与痰浊阻遏证组间比较无统计学差异(P＞0.05),气阴两虚证组和肝肾阴虚证组间比较无统计学差异(P＞0.05),其余各组间两两比较均有统计学差异(P＜0.05)。
5.各证型组间的空腹血糖、餐后两小时血糖两两相比较无统计学差异(P＞0.05)。各证型组间甘油三酯以及高密度脂蛋白胆固醇比较,肝肾阴虚证组和脾肾气虚证组之间无统计学差异(P＞0.05),其余各证型组间两两比较有统计学差异(P＞0.05)。
6.各证型组之间血清肌酐水平以及血清肌酐清除率两两比较,无统计学差异(P＞0.05)。血清白蛋白水平,脾肾阳虚证组和气阴两虚证组间相比无统计学差异(P＞0.05),肝肾阴虚证组和脾肾气虚证组间相比亦无统计学差异(P＞0.05),其余各证型组间两两比较有统计学差异(P＜0.05)。超敏C反应蛋白水平,痰瘀互结证组和痰浊阻遏证组间相比无统计学差异(P＞0.05),脾肾阳虚证组和气阴两虚证组间相比无统计学差异(P＞0.05),肝肾阴虚证组和脾肾气虚证组间相比无统计学差异(P＞0.05),其余各证型组间两两比较有统计学差异(P＜0.05)。
7.各证型组间脉压、颈-股脉搏波速度比较:痰瘀互结证组＞痰浊阻遏证组＞脾肾阳虚证组＞气阴两虚证组＞肝肾阴虚证组＞脾肾气虚证组,各组间两两比较有统计学差异(P＜0.05)。
8.对所有研究对象证型分布与颈-股脉搏波速度分级进行比较分析,结果显示各组间脉搏波速度等级构成比存在显著差异(P＜0.05)。其中痰瘀互结证组患者中、重度患者比例明显高于其余各组(P＜0.05),而脾肾气虚证组中脉搏波速度评价为正常的患者比例高于其余各组(P＜0.05),且未出现重度的患者。正常患者在各证型组中所占比例比较结果:脾肾气虚证＞肝肾阴虚证＞气阴两虚证＞脾肾阳虚证＞痰浊阻遏证＞痰瘀互结证。
9.颈-股脉搏波速度和年龄、SBP、PP呈正相关,有显著统计学意义(P＜0.001),与甘油三酯、超敏C反应蛋白呈正相关,有统计学意义(P＜0.05);与高密度脂蛋白胆固醇、血清白蛋白呈负相关,有统计学意义(P＜0.05)。
10.多元逐步回归分析结果表明,年龄、收缩压、脉压和高密度脂蛋白胆固醇是影响患者颈-股脉搏波速度的独立因素,调整决定系数为0.567,回归方程为颈-股脉搏波速度(m/s)=2.981+0.025年龄(岁)+0.032收缩压(mmHg)+0.044脉压(mmHg)+0.230高密度脂蛋白胆固醇,(各偏回归系数P＜0.05)。
结论:
1.伴代谢综合征的慢性肾脏病人中医证型以痰浊阻遏型和痰瘀互结型居多。
2.研究发现,伴代谢综合征的慢性肾脏病患者的各项生化指标均明显高于正常对照组。
3.不同证型组间各项指标存在一定的差异,痰瘀互结型和痰浊阻遏型的各项指标与其它各证型组间存在明显差异,各中医证型组间大动脉僵硬度的变化与中医证型衍化规律一致,可作为辩证伴代谢综合征的慢性肾脏病人的客观指标及疗效参考评价依据。
Objective:To study the relationship between the level of blood glucose,blood fat,body mass index(BMI),waist circuferrence,blood pressure,pulse pressure, carotid-femoral pulse wave velocity(CF-PWV)and the different TCM syndrome in Chronic Kidney Disease(CKD)patients with Metabolic Syndrome(MS),in order to find the objective evidence of differentiation of symptoms and signs of traditional Chinese medicine of metabolic syndrome and to guide clinic treatment better.
Methods:Two hundred and forty seven CKD patients with MS were divided into six group through TCM differentiation,the deficiency of spleen Qi and kidney Qi syndrome group,the deficiency of Qi and Yin syndrome group,the deficiency of liver Yin and kidney Yin syndrome group,the deficiency of spleen yang and kidney yang syndrome group,the phlegm and abiding spleen syndrome group,the phlegm and blood stasis syndrome group.Twenty one patients belonged to the deficiency of spleen Qi and kidney Qi syndrome group,twenty nine patients belonged to the deficiency of Qi and Yin syndrome group,twenty six patients belonged to the deficiency of liver Yin and kidney Yin syndrome group,forty three patients belonged to the deficiency of spleen yang and kidney yang syndrome group,sixty nine patients belonged to the phlegm and abiding spleen syndrome group,fifty nine patients belonged to the phlegm and blood stasis syndrome group.Body height,body weight and waist circumference were measured. BMI was calculated.Blood glucose,blood fat,serum albumin,creatinine, creatinine clearance rate(Ccr),supersensitive C reactive protein(sCRP), CF-PWV,and etc,were checked.Analysis the differences of all the indices between each TCM syndrome group.Analysis the dependability between carotid-femoral pulse wave velocity and other indices.In addition,all the indices of the control group(50 persons)who were healthy were checked and compared with all the groups of metabolic syndrome.
Results:
1.The main TCM syndrome of the CKD patients with MS was phlegm and abiding spleen syndrome(27%),and others were phlegm and blood stasis syndrome(24%), the deficiency of spleen yang and kidney yang syndrome(17%),the deficiency of Qi and Yin syndrome(12%),the deficiency of liver Yin and kidney Yin syndrome(11%)and the deficiency of spleen Qi and kidney Qi syndrome(9%).
2.The proportion of CKD stage in each TCM syndrome group were different.The deficiency of spleen Qi and kidney Qi syndrome group,the deficiency of Qi and Yin syndrome group;and the deficiency of liver Yin and kidney Yin syndrome group are mainly in CKD stage 1,CKD stage 2 and CKD stage 3.But in the deficiency of spleen yang and kidney yang syndrome group,phlegm and abiding spleen syndrome group and phlegm and blood stasis syndrome group were mainly in CKD stage 4 and CKD stage 5.
3.BMI,waist circumference,fasting blood glucose,blood glucose after meal, trig]yceride(TG),high density lipid cholesterol(HDL-C),creatinine,sCRP, systolic blood pressure,diastolic blood pressure,pulse pressure and CF-PWV of each TCM syndrome group were all higher than the control group(P＞0.05);the serum albumin and Ccr were lower than the control group(P＜0.05).
4.BMI and waist circumference of phlegm and blood stasis syndrome group were significant higher than any other group(P＜0.05),there was no significant difference of BMI between phlegm and blood stasis syndrome group and phlegm and abiding spleen syndrome group(P＞0.05),and also no significant difference between the deficiency of Qi and Yin syndrome group and the deficiency of spleen Qi and kidney Qi syndrome group(P＞0.05),and there was significant difference of BMI between the other groups(P＜0.05);there was no significant difference of waist circumference between phlegm and blood stasis syndrome group and phlegm and abiding spleen syndrome group(P＞0.05),and also no significant difference between the deficiency of Qi and Yin syndrome group and the deficiency of liver Yin and kidney Yin syndrome group(P＞0.05);and there was significant difference of waist circumference between the other groups(P＜0.05).
5.There was no significant difference of fasting blood glucose and blood glucose after meal betweeneach TCM syndrome group(P＞0.05);there were no significant difference of TG and HDL-C between the deficiency of liver Yin and kidney Yin syndrome group and the deficiency of spleen Qi and kidney Qi syndrome group,(P＞0.05);and there was significant difference of TG and HDL-C between the other groups(P＜0.05).
6.There was no significant difference of creatinine and creatinine clearance rate among each TCM syndrome group(P＞0.05);there was no significant difference of serum albumin between spleen yang and kidney yang syndrome group and the deficiency of Qi and Yin syndrome group(P＞0.05);and also no significant difference between the liver Yin and kidney Yin syndrome group and the deficiency of spleen Qi and kidney Qi syndrome group(P＞0.05);and there was significant difference of serum albumin between the other groups(P＜0.05).There was no significant difference of sCRP between phlegm and blood stasis syndrome group and phlegm and abiding spleen syndrome group(P＞0.05),and also nosignificant difference between spleen yang and kidney yang syndrome group and the deficiency of Qi and Yin syndrome group; and there was significant difference of sCRP between the other groups(P＜0.05).
7.The pulse pressure and CF-PWV:phlegm and blood stasis syndrome group＞phlegm and abiding spleen syndrome group＞spleen yang and kidney yang syndrome group＞the deficiency of Qi and Yin syndrome group＞the deficiency of liver Yin and kidney Yin syndrome group＞the deficiency of spleen Qi and kidney Qi syndrome group,there was significant difference between each group(P＜0.05).
8.There was significant difference of CF-PWV level proportion between each group(P＜0.05);the proportion of sever level patients of phlegm and blood stasis syndrome group was significantly higher than any other group(P＜0.05);the proportion of normal level patients of he deficiency of spleen Qi and kidney Qi syndrome group was significantly higher than any other group(P＜0.05),the deficiency of spleen Qi and kidney Qi syndrome group＞the deficiency of liver Yin and kidney Yin syndrome group＞the deficiency of Qi and Yin syndrome group＞spleen yang and kidney yang syndrome group＞phlegm and abiding spleen syndrome group＞phlegm and blood stasis syndrome group(P＜0.05).
9.There was significant positive correlation between CF-PWV and age,systolic blood pressure,pulse pressure(P＜0.001);there was positive correlation between CF-PWV and TG,sCRP(P＜0.05);there was negative correlation between
CF-PWV and HDL-C,Alb(P＜0.05).
10.In a multivariate regression analysis,CF-PWV was independently determined by age(＜0.05),SBP(＜0.05),PP(＜0.05),and HDL-C(＜0.05).Adjusted R~2 of the model was 0.567.The regression equation:CF-PWV(m/s)=2.981+0.025 age(years old)+0.032SBP(mmHg)+0.044PP(mmHg)+0.230HDL-C.
Conclusion:
1.The most common TCM syndrome in CKD patients with MS were phlegm and blood stasis syndrome and phlegm and abiding spleen syndrome.
2.There is high level of all the indices in the CKD patients with MS.
3.There was significant difference of the indices between each TCM syndrome group.There was close relationship between TCM syndrome and the indices.CF-PWV could be the objective evidence of different TCM syndrome.And the CF-PWV could be utilized as an index to evaluate the clinical effect and prognosis.
探讨伴代谢综合征的慢性肾脏病患者的大动脉僵硬度、体重指数及血脂等指标的变化趋势,为中医证的客观化研究做有益探讨。
方法:
本研究纳入伴代谢综合征的慢性肾脏病患者247例,按临床症状、舌象、脉象辩证,按中医辩证分型,分为六个证型组,即脾肾气虚型组、气阴两虚型组、肝肾阴虚型组、脾肾阳虚型组、痰浊阻遏型组、痰瘀互结型组。其中脾肾气虚型组21例、气阴两虚型组29例,肝肾阴虚型组26例,脾肾阳虚型组43例,痰浊阻遏型组69例,痰瘀互结型组59例。分析证型分布规律,并同时测定其体重指数、腰围、血糖、血脂、血清白蛋白、血清肌酐、血清肌酐清除率、超敏C反应蛋白、颈-股脉搏波速度等指标,分析各证型上述指标的差异以及颈-股脉搏波速与各项相关指标的相关性分析。
结果:
1.伴代谢综合征的慢性肾脏病患者中医辨证以痰浊阻遏型所占比例最大(27%),其后依次为痰瘀互结型(24%)、脾肾阳虚型(17%),气阴两虚型(12%)、肝肾阴虚型(11%)和脾肾气虚型(9%)。
2.各证型组间不同慢性肾脏病分期的比例不一,但在脾肾气虚证组、气阴两虚证组以及肝肾阴虚证组中主要集中以慢性肾脏病1期、2期、3期为主,而在脾肾阳虚证组、痰浊阻遏证组以及痰瘀互结证组中,慢性肾脏病1期、2期、3期比例明显减少,慢性肾脏病4、5期比例明显增多。
3.各证型组的体重指数、腰围、空腹血糖、餐后两小时血糖、甘油三酯、高密度脂蛋白胆固醇、血清肌酐水平、超敏C反应蛋白水平、收缩压、舒张压、脉压以及颈-股脉搏波速均较正常组高,有统计学差异(P＜0.05);各证型组的血清肌酐清除率以及血清白蛋白水平明显低于正常对照组,有统计学差异(P＜0.05)。
4.痰瘀互结证组的体重指数以及腰围均较其它证型组高,有统计学差异(P＜0.05)。各证型组间体重指数比较,痰瘀互结证组与痰浊阻遏证组间比较无统计学差异(P＞0.05),脾肾气虚证组和气阴两虚证组间比较无统计学差异(P＞0.05),其余各组间两两比较均有统计学差异(P＜0.05);各证型组间腰围比较,痰瘀互结证组与痰浊阻遏证组间比较无统计学差异(P＞0.05),气阴两虚证组和肝肾阴虚证组间比较无统计学差异(P＞0.05),其余各组间两两比较均有统计学差异(P＜0.05)。
5.各证型组间的空腹血糖、餐后两小时血糖两两相比较无统计学差异(P＞0.05)。各证型组间甘油三酯以及高密度脂蛋白胆固醇比较,肝肾阴虚证组和脾肾气虚证组之间无统计学差异(P＞0.05),其余各证型组间两两比较有统计学差异(P＞0.05)。
6.各证型组之间血清肌酐水平以及血清肌酐清除率两两比较,无统计学差异(P＞0.05)。血清白蛋白水平,脾肾阳虚证组和气阴两虚证组间相比无统计学差异(P＞0.05),肝肾阴虚证组和脾肾气虚证组间相比亦无统计学差异(P＞0.05),其余各证型组间两两比较有统计学差异(P＜0.05)。超敏C反应蛋白水平,痰瘀互结证组和痰浊阻遏证组间相比无统计学差异(P＞0.05),脾肾阳虚证组和气阴两虚证组间相比无统计学差异(P＞0.05),肝肾阴虚证组和脾肾气虚证组间相比无统计学差异(P＞0.05),其余各证型组间两两比较有统计学差异(P＜0.05)。
7.各证型组间脉压、颈-股脉搏波速度比较:痰瘀互结证组＞痰浊阻遏证组＞脾肾阳虚证组＞气阴两虚证组＞肝肾阴虚证组＞脾肾气虚证组,各组间两两比较有统计学差异(P＜0.05)。
8.对所有研究对象证型分布与颈-股脉搏波速度分级进行比较分析,结果显示各组间脉搏波速度等级构成比存在显著差异(P＜0.05)。其中痰瘀互结证组患者中、重度患者比例明显高于其余各组(P＜0.05),而脾肾气虚证组中脉搏波速度评价为正常的患者比例高于其余各组(P＜0.05),且未出现重度的患者。正常患者在各证型组中所占比例比较结果:脾肾气虚证＞肝肾阴虚证＞气阴两虚证＞脾肾阳虚证＞痰浊阻遏证＞痰瘀互结证。
9.颈-股脉搏波速度和年龄、SBP、PP呈正相关,有显著统计学意义(P＜0.001),与甘油三酯、超敏C反应蛋白呈正相关,有统计学意义(P＜0.05);与高密度脂蛋白胆固醇、血清白蛋白呈负相关,有统计学意义(P＜0.05)。
10.多元逐步回归分析结果表明,年龄、收缩压、脉压和高密度脂蛋白胆固醇是影响患者颈-股脉搏波速度的独立因素,调整决定系数为0.567,回归方程为颈-股脉搏波速度(m/s)=2.981+0.025年龄(岁)+0.032收缩压(mmHg)+0.044脉压(mmHg)+0.230高密度脂蛋白胆固醇,(各偏回归系数P＜0.05)。
结论:
1.伴代谢综合征的慢性肾脏病人中医证型以痰浊阻遏型和痰瘀互结型居多。
2.研究发现,伴代谢综合征的慢性肾脏病患者的各项生化指标均明显高于正常对照组。
3.不同证型组间各项指标存在一定的差异,痰瘀互结型和痰浊阻遏型的各项指标与其它各证型组间存在明显差异,各中医证型组间大动脉僵硬度的变化与中医证型衍化规律一致,可作为辩证伴代谢综合征的慢性肾脏病人的客观指标及疗效参考评价依据。
Objective:To study the relationship between the level of blood glucose,blood fat,body mass index(BMI),waist circuferrence,blood pressure,pulse pressure, carotid-femoral pulse wave velocity(CF-PWV)and the different TCM syndrome in Chronic Kidney Disease(CKD)patients with Metabolic Syndrome(MS),in order to find the objective evidence of differentiation of symptoms and signs of traditional Chinese medicine of metabolic syndrome and to guide clinic treatment better.
Methods:Two hundred and forty seven CKD patients with MS were divided into six group through TCM differentiation,the deficiency of spleen Qi and kidney Qi syndrome group,the deficiency of Qi and Yin syndrome group,the deficiency of liver Yin and kidney Yin syndrome group,the deficiency of spleen yang and kidney yang syndrome group,the phlegm and abiding spleen syndrome group,the phlegm and blood stasis syndrome group.Twenty one patients belonged to the deficiency of spleen Qi and kidney Qi syndrome group,twenty nine patients belonged to the deficiency of Qi and Yin syndrome group,twenty six patients belonged to the deficiency of liver Yin and kidney Yin syndrome group,forty three patients belonged to the deficiency of spleen yang and kidney yang syndrome group,sixty nine patients belonged to the phlegm and abiding spleen syndrome group,fifty nine patients belonged to the phlegm and blood stasis syndrome group.Body height,body weight and waist circumference were measured. BMI was calculated.Blood glucose,blood fat,serum albumin,creatinine, creatinine clearance rate(Ccr),supersensitive C reactive protein(sCRP), CF-PWV,and etc,were checked.Analysis the differences of all the indices between each TCM syndrome group.Analysis the dependability between carotid-femoral pulse wave velocity and other indices.In addition,all the indices of the control group(50 persons)who were healthy were checked and compared with all the groups of metabolic syndrome.
Results:
1.The main TCM syndrome of the CKD patients with MS was phlegm and abiding spleen syndrome(27%),and others were phlegm and blood stasis syndrome(24%), the deficiency of spleen yang and kidney yang syndrome(17%),the deficiency of Qi and Yin syndrome(12%),the deficiency of liver Yin and kidney Yin syndrome(11%)and the deficiency of spleen Qi and kidney Qi syndrome(9%).
2.The proportion of CKD stage in each TCM syndrome group were different.The deficiency of spleen Qi and kidney Qi syndrome group,the deficiency of Qi and Yin syndrome group;and the deficiency of liver Yin and kidney Yin syndrome group are mainly in CKD stage 1,CKD stage 2 and CKD stage 3.But in the deficiency of spleen yang and kidney yang syndrome group,phlegm and abiding spleen syndrome group and phlegm and blood stasis syndrome group were mainly in CKD stage 4 and CKD stage 5.
3.BMI,waist circumference,fasting blood glucose,blood glucose after meal, trig]yceride(TG),high density lipid cholesterol(HDL-C),creatinine,sCRP, systolic blood pressure,diastolic blood pressure,pulse pressure and CF-PWV of each TCM syndrome group were all higher than the control group(P＞0.05);the serum albumin and Ccr were lower than the control group(P＜0.05).
4.BMI and waist circumference of phlegm and blood stasis syndrome group were significant higher than any other group(P＜0.05),there was no significant difference of BMI between phlegm and blood stasis syndrome group and phlegm and abiding spleen syndrome group(P＞0.05),and also no significant difference between the deficiency of Qi and Yin syndrome group and the deficiency of spleen Qi and kidney Qi syndrome group(P＞0.05),and there was significant difference of BMI between the other groups(P＜0.05);there was no significant difference of waist circumference between phlegm and blood stasis syndrome group and phlegm and abiding spleen syndrome group(P＞0.05),and also no significant difference between the deficiency of Qi and Yin syndrome group and the deficiency of liver Yin and kidney Yin syndrome group(P＞0.05);and there was significant difference of waist circumference between the other groups(P＜0.05).
5.There was no significant difference of fasting blood glucose and blood glucose after meal betweeneach TCM syndrome group(P＞0.05);there were no significant difference of TG and HDL-C between the deficiency of liver Yin and kidney Yin syndrome group and the deficiency of spleen Qi and kidney Qi syndrome group,(P＞0.05);and there was significant difference of TG and HDL-C between the other groups(P＜0.05).
6.There was no significant difference of creatinine and creatinine clearance rate among each TCM syndrome group(P＞0.05);there was no significant difference of serum albumin between spleen yang and kidney yang syndrome group and the deficiency of Qi and Yin syndrome group(P＞0.05);and also no significant difference between the liver Yin and kidney Yin syndrome group and the deficiency of spleen Qi and kidney Qi syndrome group(P＞0.05);and there was significant difference of serum albumin between the other groups(P＜0.05).There was no significant difference of sCRP between phlegm and blood stasis syndrome group and phlegm and abiding spleen syndrome group(P＞0.05),and also nosignificant difference between spleen yang and kidney yang syndrome group and the deficiency of Qi and Yin syndrome group; and there was significant difference of sCRP between the other groups(P＜0.05).
7.The pulse pressure and CF-PWV:phlegm and blood stasis syndrome group＞phlegm and abiding spleen syndrome group＞spleen yang and kidney yang syndrome group＞the deficiency of Qi and Yin syndrome group＞the deficiency of liver Yin and kidney Yin syndrome group＞the deficiency of spleen Qi and kidney Qi syndrome group,there was significant difference between each group(P＜0.05).
8.There was significant difference of CF-PWV level proportion between each group(P＜0.05);the proportion of sever level patients of phlegm and blood stasis syndrome group was significantly higher than any other group(P＜0.05);the proportion of normal level patients of he deficiency of spleen Qi and kidney Qi syndrome group was significantly higher than any other group(P＜0.05),the deficiency of spleen Qi and kidney Qi syndrome group＞the deficiency of liver Yin and kidney Yin syndrome group＞the deficiency of Qi and Yin syndrome group＞spleen yang and kidney yang syndrome group＞phlegm and abiding spleen syndrome group＞phlegm and blood stasis syndrome group(P＜0.05).
9.There was significant positive correlation between CF-PWV and age,systolic blood pressure,pulse pressure(P＜0.001);there was positive correlation between CF-PWV and TG,sCRP(P＜0.05);there was negative correlation between
CF-PWV and HDL-C,Alb(P＜0.05).
10.In a multivariate regression analysis,CF-PWV was independently determined by age(＜0.05),SBP(＜0.05),PP(＜0.05),and HDL-C(＜0.05).Adjusted R~2 of the model was 0.567.The regression equation:CF-PWV(m/s)=2.981+0.025 age(years old)+0.032SBP(mmHg)+0.044PP(mmHg)+0.230HDL-C.
Conclusion:
1.The most common TCM syndrome in CKD patients with MS were phlegm and blood stasis syndrome and phlegm and abiding spleen syndrome.
2.There is high level of all the indices in the CKD patients with MS.
3.There was significant difference of the indices between each TCM syndrome group.There was close relationship between TCM syndrome and the indices.CF-PWV could be the objective evidence of different TCM syndrome.And the CF-PWV could be utilized as an index to evaluate the clinical effect and prognosis.
引文
[1]Eckel RH,Grundy SM,Zimmet PZ.The metabolic syndrome[J].Lancet,2005,365:1425-1428.
[2]Chen J,Paul M,Lee Hamm,et al.The metabolic syndrome and chronic kidney Disease in USA adults[J].Annals of Internal Medicine,2004,140(3):167-174.
[3]边琪,袁伟杰,鲁维维,等.代谢综合征及其代谢因子与慢性肾损害相关性的临床研究[J].中华肾病杂志,2005,7(1):389-393.
[4]Frod ES,Giles WH.A comparison of the prevalence of the metabolic syndrome using two proposed definitions.Diabetes care,2003,26:575-581.
[5]顾东风,Reynolds K,杨文杰,等.中国成年人代谢综合征的患病率.中国糖尿病杂志,2005,13(3):181-186.
[6]王玲玲,胡美英.广州市员村社区居民代谢综合征流行病学现状调查,广东医学,2006,27(4):577-579.
[7]Grundy,Scott M.Metabolic Syndrome Scientific Statement by the American Heart Association and the National Heart,Lung,and Blood Institute.Arteriosclerosis,Thrombosis & Vascular Biology.2005,25(11):2243-2244.
[8]Lakka HM,Laaksonen DE,Lakka TA,et al.The metabolic syndrome and total and cardiovascular disease mortality in middle aged men.JAMA,2002,288:2709-2716.
[9]金雪梅,陈灏珠.代谢综合征与心血管疾病关系概述[J].中国实用内科杂志,2006,26(1):54-56.
[10]Adams RJ,App reton S,Wilson DH,et al.Population comparison of Two clinical Approaches to the Metabolic syndrome Implication of the new International Diabetes Federation consensus definition[J].Diabetes Care,2005,28(11):2777-2779.
[11]Shoelson SE,Lee J,Oldfine AB.Inflammation and insulin resistance[J].J ClinInvest,2006,116(7):1793-1801.
[12]HaagM,DippenaarNG.Dietary fats,fatty acids and insulin resistance:Short review of a multifaceted connection[J].Med SciMonit,2005,11(12):RA359-367.
[13]Barish OD,Narkar VA,Evans RM.PPAR delta:A dagger in the heart of the metabolic syndrome[J].J Clan Invest,2006,116(3):590-597.
[14]Das UN.Pyruvate is an endogenous antiinflammatory and antioxidant molecule[J].Med SciMonit,2006,12(5):RA79-84.
[15]Hewitt KN,Walker EA,Stewart PM.Minireview:Hexose-6-phosphate dehydrogenase and redox control of 11{ beta}-hydroxysteroid dehydrogenase type 1 activity[J].Endocrinology,2005,146(6):2539-2543.
[16]Fisler JS,Warden CH.Uncoupling proteins,dietary fat and the metabolic syndrome[J].NutrMetab,2006,3(1):38.
[17]HaydenMR,Sowers JR,Tyagi SC.The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes:The matrix p reloaded[J].Cardiovasc Diabetol,2005,4(1):9.
[18]Gallou,Kabani C,Junien C.Nutritional epigenomics of metabolic syndrome:New perspective against the epidemic[J].Diabetes,2005,54(7):1899-1906.
[19]Isomaa B,Almgren P,Tuomi T,et al.Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care,2001,24:683-689.
[20]安维洲,张磊.代谢综合征研究进展[J]国外医学·内分泌分册,2005,25(5):137-141.
[21]李兴武,王麟.代谢综合征研究进展[J]国外医学·老年医学分册,2004;25(5):230-233.
[22]刘坤申,刘刚.血脂异常与高血压[J]中国实用内科杂志,2004;24(3):262-264.
[23]Hamasak i S,AL Suwaidi J,H igano ST,at al.Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy[J].J Am Gou Cardiol,2000;35(13):1654-1660.
[24]迟东升,刘伊丽高血压心肌微血管病变的研究进展[J].高血压杂志,2004;12(6):495-497.
[25]黄从新.糖尿病血脂异常与心血管并发症的现代认识[J].中国实用内科杂志,2004;24(3):265-268.
[26]金雪梅,陈灏珠.代谢综合征与心血管疾病关系概述[J].中国实用内科杂志,2006,26(1):54-56.
[27]Adams RJ,Appreton S,Wilson DH,etal.Population comparison of Two clinical Approaches to the Metabolic syndrome Implication of the new International Diabetes Federation consensus definition[J].Diabetes Care,2005,28(11):2777-2779.
[28]Chen J,Paul M,Lee Hamm,et al.The metabolic syndrome and chronic kidney Disease in USA adults[J].Annals of Internal Medicine,2004,140(3):167-174.
[29]边琪,袁伟杰,鲁维维等.代谢综合征及其代谢因子与慢性肾损害相关性的临床研究[J].中华肾病杂志,2005,7(1):389-393.
[30]曾定尹.血脂异常与代谢综合征[J].中国实用内科杂志,2004,24(5):1269-1271.
[31]Sarnak MJ,Levey AS,Schoolwerth AC,et al.Kidney disease as arisk factor for development of cardiovascular disease:A tatement from the American Heart Association Councils on Kidney in Cardiovascular Disease,High Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention.Hypertension,2003,42:1050.
[32]Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.Am J Kidney Dis,2004,44(2):198-206.
[33]Chen,Jing;Gu,Dongfeng;Chen,Chung-Shiuan;Wu,Xigui;Hamm,L.Lee;Muntner,Paul;Batuman,Vecihi;Lee,Chien-Hung;Whelton,Paul K.;He,Jiang.Association between the metabolic syndrome and chronic kidney disease in Chinese adults.Nephrology Dialysis Transplantation.22(4):1100-1106,April 2007.
[34]仝小林,段军.代谢综合征的中医认识和治疗[J].中日友好医院学报,2002,16(5-6):347.
[35]Konings CJ,Dammers R,Hensma PL,et al.Arterial wall properties in patients with renal failure[J].Am J Kidney Dis,2002,39(6):1206-1212.
[36]Blacher J,Guerin AP,Pannier B,et al.Impact of aortic stiffness on survival in end-stage renal disease[J].Circulation,1999,99:2434-2439.
[37]Takeuchi K,Zhang B,Ideishi M,et al.Influence of age and hypertension on theassociation between small artery compliance and coronary artery disease[J].Am J Hypertens,2004,17(12 Pti):1188-1191.
[38]McVeigh GE,Bratteli CW,Morgan DJ,et al.Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis:Aging and arterial compliance[J].Hypertension,1999,33:1392-1398.
[39]Franklin SS,GustinW,Wong ND,et al.Hemodynamic patterns of age-related changes in blood pressure.The Framingham Heart Study[]].Circulation,1997,96:308-315.
[40]陈小明,林金秀,苏津自,等.正常高值血压人群动脉弹性功能的变化[J].心脑血管病防治,2003,3(4):11-13.
[41]Mikawa T.Anti-hypertensive drugs associated with the improvement of pulse wave velocity[J].Nippon Rinshol,2004,62(12):2345-2351.
[42]Prisant LM,Resnick LM,Hollenberg SM,et al.Arterial elasticity among normotensive subjects and treated and untreated hypertensive subjects[J].Blood Press Monitor,2001,6(5):233-237.
[43]Francesco P,Roberto C,Arturo P,et al Prognostic significance of endothelial dysfunction in hypertensive patients[J].Circulation,2001,104(2):191-196.
[44]Tounian P,Aggoun Y,Dubern B,et al Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children:a prospective study[J].Lancet 2001,358:1400-1404.
[45]Nickenig G,Roling J,Strehlow K,et al.Insulin induce supregulation of vascular AT1 receptor gene expression by post transcriptional mechanisms [J].Circulation,1998,98:2453-2460.
[46]Konings CJ,Dammers R,Rensma PL,et al.Arterial wall properties in patients with renal failure[J].Am J Kidney Dis,2002,39(6):1206-1212.
[47]Blacher J,Guerin AP,Pannier B,et al.Impact of aortic stiffness on survival in end-stage renal disease[J].Circulation,1999,99:2434-2439.
[48]Kim JW,Park CG,Hong SJ,et al.Acute and chronic effects of cigarette smoking on arterial stiffness[J].Blood Press,2005,14(2):80-85.
[49]Mack WJ,Islam T,hee Z,et al.Environmental tobacco smoke and carotid arterial stiffness[J].PrevMed,2003,37(2):148-154.
[50]王杰超,王建华.动脉弹性功能研究的现状和意义.临床荟萃,2006,21(24):1798-1800.
[51]张竹林.动脉弹性与代谢综合征.心血管病学进展,2006,27(6):728-731.
[52]高磊.动脉顺应性的研究进展,心血管病学进展,2007,28(1):74-76.
[53]倪永斌,李翠兰.血管病变研究新视角—动脉硬度、脉搏波和脉压,心血管病学进展,2007,28(1):3-6.
[54]Boutouyrie P,Tropeano AI,Asmar R,Gautier I,Benetos A,Lacolley P,et al.Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients:a longitudinal study[J].Hypertension,2002,39(1):10-15.
[55]Laurent S,Boutouyrie P,Asmar R,Gautier I,Laloux B,Guize L,et al.Aortic stiffness is an independent predictor of all Cause and cardiovascular mortality in hypertensive patients[J].Hypertension,2001,37(5):1236-241.
[56]Roland Asmar,王宏宇(译).动脉僵硬度和脉搏波速的临床应用.人民军医出 版社,北京2005年11月第一版.
[57]Glaser SP,Arnett DK,Mcveigh GE,et al.Vascular compliance and cardiovascular disease.A risk factor or a marker[J].Am J Hypertens,1997,10:1175-1189.
[58]仝小林,段军.代谢综合征的中医认识和治疗[J].中日友好医院学报,2002,16(5～6):347.
[59]徐远.中医治疗代谢综合征的思路与方法[J].中医杂志,2003,44(4):301.
[60]叶子,张世珍.代谢综合征的中医认识和治疗[J].中国中西医结合杂志,2005,25(7):599.
[61]王德玉,徐志瑛.代谢综合征辨证探析[J].浙江中医学院学报,2005,29(1):12.
[62]《中医临床诊疗术语—证候部分》.中华人民共和国国家标准,GB/T16751.2-1997.
[63]郑筱萸主编.中药新药临床研究指导原则.中国医药科技出版社.2002:73-77,163-168.
[64]第二次全国中医肾病专题学术讨论会,慢性肾功能衰竭中医辩证分型参考意见.
[65]守山敏树.代谢综合征与慢性肾脏病.日本医学介绍.2007,28(7):309-312.
[66]Sarnak MJ,hevey AS,Schoolwerth AC,et al.Kidney disease as a risk factor for development of cardiovascular disease:A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease,High Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention.Hypertension,2003,42:1050.
[67]Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.Am J Kidney Dis,2004,44(2):198-206.
[68]黄燕萍.慢性肾脏病患者心血管疾病的研究现状.国际泌尿系统杂,2007,27(2):234-237.
[69]Chen Jing,Gu Dongfeng,Chen Chung-Shiuan,Wu Xigui,HammL Lee,Muntner Paul,Batuman,Vecihi Lee,Chien Hung,Whelton,Paul K,He Jiang.Association between the metabolic syndrome and chronic kidney disease in Chinese adults.Nephrology Dialysis Transplantation.22(4):1100-1106,April 2007.
[70]谭静,华琦,闻静等.代谢综合征与动脉僵硬度的关系.中国动脉硬化杂志,2006,14(2):167-169.
[71]倪永斌,张维忠,王宏宇,等.高血压病脉搏波速度与脉压关系的研究[J].中华心血管病杂志,2003,31:257-259.
[2]Chen J,Paul M,Lee Hamm,et al.The metabolic syndrome and chronic kidney Disease in USA adults[J].Annals of Internal Medicine,2004,140(3):167-174.
[3]边琪,袁伟杰,鲁维维,等.代谢综合征及其代谢因子与慢性肾损害相关性的临床研究[J].中华肾病杂志,2005,7(1):389-393.
[4]Frod ES,Giles WH.A comparison of the prevalence of the metabolic syndrome using two proposed definitions.Diabetes care,2003,26:575-581.
[5]顾东风,Reynolds K,杨文杰,等.中国成年人代谢综合征的患病率.中国糖尿病杂志,2005,13(3):181-186.
[6]王玲玲,胡美英.广州市员村社区居民代谢综合征流行病学现状调查,广东医学,2006,27(4):577-579.
[7]Grundy,Scott M.Metabolic Syndrome Scientific Statement by the American Heart Association and the National Heart,Lung,and Blood Institute.Arteriosclerosis,Thrombosis & Vascular Biology.2005,25(11):2243-2244.
[8]Lakka HM,Laaksonen DE,Lakka TA,et al.The metabolic syndrome and total and cardiovascular disease mortality in middle aged men.JAMA,2002,288:2709-2716.
[9]金雪梅,陈灏珠.代谢综合征与心血管疾病关系概述[J].中国实用内科杂志,2006,26(1):54-56.
[10]Adams RJ,App reton S,Wilson DH,et al.Population comparison of Two clinical Approaches to the Metabolic syndrome Implication of the new International Diabetes Federation consensus definition[J].Diabetes Care,2005,28(11):2777-2779.
[11]Shoelson SE,Lee J,Oldfine AB.Inflammation and insulin resistance[J].J ClinInvest,2006,116(7):1793-1801.
[12]HaagM,DippenaarNG.Dietary fats,fatty acids and insulin resistance:Short review of a multifaceted connection[J].Med SciMonit,2005,11(12):RA359-367.
[13]Barish OD,Narkar VA,Evans RM.PPAR delta:A dagger in the heart of the metabolic syndrome[J].J Clan Invest,2006,116(3):590-597.
[14]Das UN.Pyruvate is an endogenous antiinflammatory and antioxidant molecule[J].Med SciMonit,2006,12(5):RA79-84.
[15]Hewitt KN,Walker EA,Stewart PM.Minireview:Hexose-6-phosphate dehydrogenase and redox control of 11{ beta}-hydroxysteroid dehydrogenase type 1 activity[J].Endocrinology,2005,146(6):2539-2543.
[16]Fisler JS,Warden CH.Uncoupling proteins,dietary fat and the metabolic syndrome[J].NutrMetab,2006,3(1):38.
[17]HaydenMR,Sowers JR,Tyagi SC.The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes:The matrix p reloaded[J].Cardiovasc Diabetol,2005,4(1):9.
[18]Gallou,Kabani C,Junien C.Nutritional epigenomics of metabolic syndrome:New perspective against the epidemic[J].Diabetes,2005,54(7):1899-1906.
[19]Isomaa B,Almgren P,Tuomi T,et al.Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care,2001,24:683-689.
[20]安维洲,张磊.代谢综合征研究进展[J]国外医学·内分泌分册,2005,25(5):137-141.
[21]李兴武,王麟.代谢综合征研究进展[J]国外医学·老年医学分册,2004;25(5):230-233.
[22]刘坤申,刘刚.血脂异常与高血压[J]中国实用内科杂志,2004;24(3):262-264.
[23]Hamasak i S,AL Suwaidi J,H igano ST,at al.Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy[J].J Am Gou Cardiol,2000;35(13):1654-1660.
[24]迟东升,刘伊丽高血压心肌微血管病变的研究进展[J].高血压杂志,2004;12(6):495-497.
[25]黄从新.糖尿病血脂异常与心血管并发症的现代认识[J].中国实用内科杂志,2004;24(3):265-268.
[26]金雪梅,陈灏珠.代谢综合征与心血管疾病关系概述[J].中国实用内科杂志,2006,26(1):54-56.
[27]Adams RJ,Appreton S,Wilson DH,etal.Population comparison of Two clinical Approaches to the Metabolic syndrome Implication of the new International Diabetes Federation consensus definition[J].Diabetes Care,2005,28(11):2777-2779.
[28]Chen J,Paul M,Lee Hamm,et al.The metabolic syndrome and chronic kidney Disease in USA adults[J].Annals of Internal Medicine,2004,140(3):167-174.
[29]边琪,袁伟杰,鲁维维等.代谢综合征及其代谢因子与慢性肾损害相关性的临床研究[J].中华肾病杂志,2005,7(1):389-393.
[30]曾定尹.血脂异常与代谢综合征[J].中国实用内科杂志,2004,24(5):1269-1271.
[31]Sarnak MJ,Levey AS,Schoolwerth AC,et al.Kidney disease as arisk factor for development of cardiovascular disease:A tatement from the American Heart Association Councils on Kidney in Cardiovascular Disease,High Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention.Hypertension,2003,42:1050.
[32]Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.Am J Kidney Dis,2004,44(2):198-206.
[33]Chen,Jing;Gu,Dongfeng;Chen,Chung-Shiuan;Wu,Xigui;Hamm,L.Lee;Muntner,Paul;Batuman,Vecihi;Lee,Chien-Hung;Whelton,Paul K.;He,Jiang.Association between the metabolic syndrome and chronic kidney disease in Chinese adults.Nephrology Dialysis Transplantation.22(4):1100-1106,April 2007.
[34]仝小林,段军.代谢综合征的中医认识和治疗[J].中日友好医院学报,2002,16(5-6):347.
[35]Konings CJ,Dammers R,Hensma PL,et al.Arterial wall properties in patients with renal failure[J].Am J Kidney Dis,2002,39(6):1206-1212.
[36]Blacher J,Guerin AP,Pannier B,et al.Impact of aortic stiffness on survival in end-stage renal disease[J].Circulation,1999,99:2434-2439.
[37]Takeuchi K,Zhang B,Ideishi M,et al.Influence of age and hypertension on theassociation between small artery compliance and coronary artery disease[J].Am J Hypertens,2004,17(12 Pti):1188-1191.
[38]McVeigh GE,Bratteli CW,Morgan DJ,et al.Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis:Aging and arterial compliance[J].Hypertension,1999,33:1392-1398.
[39]Franklin SS,GustinW,Wong ND,et al.Hemodynamic patterns of age-related changes in blood pressure.The Framingham Heart Study[]].Circulation,1997,96:308-315.
[40]陈小明,林金秀,苏津自,等.正常高值血压人群动脉弹性功能的变化[J].心脑血管病防治,2003,3(4):11-13.
[41]Mikawa T.Anti-hypertensive drugs associated with the improvement of pulse wave velocity[J].Nippon Rinshol,2004,62(12):2345-2351.
[42]Prisant LM,Resnick LM,Hollenberg SM,et al.Arterial elasticity among normotensive subjects and treated and untreated hypertensive subjects[J].Blood Press Monitor,2001,6(5):233-237.
[43]Francesco P,Roberto C,Arturo P,et al Prognostic significance of endothelial dysfunction in hypertensive patients[J].Circulation,2001,104(2):191-196.
[44]Tounian P,Aggoun Y,Dubern B,et al Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children:a prospective study[J].Lancet 2001,358:1400-1404.
[45]Nickenig G,Roling J,Strehlow K,et al.Insulin induce supregulation of vascular AT1 receptor gene expression by post transcriptional mechanisms [J].Circulation,1998,98:2453-2460.
[46]Konings CJ,Dammers R,Rensma PL,et al.Arterial wall properties in patients with renal failure[J].Am J Kidney Dis,2002,39(6):1206-1212.
[47]Blacher J,Guerin AP,Pannier B,et al.Impact of aortic stiffness on survival in end-stage renal disease[J].Circulation,1999,99:2434-2439.
[48]Kim JW,Park CG,Hong SJ,et al.Acute and chronic effects of cigarette smoking on arterial stiffness[J].Blood Press,2005,14(2):80-85.
[49]Mack WJ,Islam T,hee Z,et al.Environmental tobacco smoke and carotid arterial stiffness[J].PrevMed,2003,37(2):148-154.
[50]王杰超,王建华.动脉弹性功能研究的现状和意义.临床荟萃,2006,21(24):1798-1800.
[51]张竹林.动脉弹性与代谢综合征.心血管病学进展,2006,27(6):728-731.
[52]高磊.动脉顺应性的研究进展,心血管病学进展,2007,28(1):74-76.
[53]倪永斌,李翠兰.血管病变研究新视角—动脉硬度、脉搏波和脉压,心血管病学进展,2007,28(1):3-6.
[54]Boutouyrie P,Tropeano AI,Asmar R,Gautier I,Benetos A,Lacolley P,et al.Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients:a longitudinal study[J].Hypertension,2002,39(1):10-15.
[55]Laurent S,Boutouyrie P,Asmar R,Gautier I,Laloux B,Guize L,et al.Aortic stiffness is an independent predictor of all Cause and cardiovascular mortality in hypertensive patients[J].Hypertension,2001,37(5):1236-241.
[56]Roland Asmar,王宏宇(译).动脉僵硬度和脉搏波速的临床应用.人民军医出 版社,北京2005年11月第一版.
[57]Glaser SP,Arnett DK,Mcveigh GE,et al.Vascular compliance and cardiovascular disease.A risk factor or a marker[J].Am J Hypertens,1997,10:1175-1189.
[58]仝小林,段军.代谢综合征的中医认识和治疗[J].中日友好医院学报,2002,16(5～6):347.
[59]徐远.中医治疗代谢综合征的思路与方法[J].中医杂志,2003,44(4):301.
[60]叶子,张世珍.代谢综合征的中医认识和治疗[J].中国中西医结合杂志,2005,25(7):599.
[61]王德玉,徐志瑛.代谢综合征辨证探析[J].浙江中医学院学报,2005,29(1):12.
[62]《中医临床诊疗术语—证候部分》.中华人民共和国国家标准,GB/T16751.2-1997.
[63]郑筱萸主编.中药新药临床研究指导原则.中国医药科技出版社.2002:73-77,163-168.
[64]第二次全国中医肾病专题学术讨论会,慢性肾功能衰竭中医辩证分型参考意见.
[65]守山敏树.代谢综合征与慢性肾脏病.日本医学介绍.2007,28(7):309-312.
[66]Sarnak MJ,hevey AS,Schoolwerth AC,et al.Kidney disease as a risk factor for development of cardiovascular disease:A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease,High Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention.Hypertension,2003,42:1050.
[67]Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.Am J Kidney Dis,2004,44(2):198-206.
[68]黄燕萍.慢性肾脏病患者心血管疾病的研究现状.国际泌尿系统杂,2007,27(2):234-237.
[69]Chen Jing,Gu Dongfeng,Chen Chung-Shiuan,Wu Xigui,HammL Lee,Muntner Paul,Batuman,Vecihi Lee,Chien Hung,Whelton,Paul K,He Jiang.Association between the metabolic syndrome and chronic kidney disease in Chinese adults.Nephrology Dialysis Transplantation.22(4):1100-1106,April 2007.
[70]谭静,华琦,闻静等.代谢综合征与动脉僵硬度的关系.中国动脉硬化杂志,2006,14(2):167-169.
[71]倪永斌,张维忠,王宏宇,等.高血压病脉搏波速度与脉压关系的研究[J].中华心血管病杂志,2003,31:257-259.